Skip to content

study of the carotid plaque

POSITRON EMISSION TOMOGRAPHY/COMPUTERIZED TOMOGRAPHY/ECOCONTRAT OF THE PLAQUE ASSOCIATED WITH CEREBRAL MAGNETIC RESONANCE FOR THE CHARACTERISATION OF THE LESION IN VIVO INTIMA-MEDIA THICKENING ATHEROSCLEROSIS AT RISK

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2012-000648-83-IT
Enrollment
Unknown
Registered
2012-07-25
Start date
2012-03-09
Completion date
Unknown
Last updated
2012-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carotid atherosclerosis at risk of atero-thrombosis MedDRA version: 14.1 Level: SOC Classification code 10007541 Term: Cardiac disorders System Organ Class: 10007541 - Cardiac disorders

Interventions

Product Name: 1[C]PK11195 Product Code: NA Pharmaceutical Form: Solution for injection INN or Proposed INN: 11[C]PK11195 Concentration unit: MBq/kg megabecquerel(s)/kilogram Concentration type: not le

Sponsors

OSPEDALE S. RAFFAELE DI MILANO
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patient of age > 40 and =65 years) yes F.1.3.1 Number of subjects for this age range 60

Exclusion criteria

Exclusion criteria: Pregnancy and breast-feeding; renal filtrate < 60 ml; patient not able to coagulate;

Design outcomes

Primary

MeasureTime frame
Main Objective: To demonstrate the clinic utility in identifying carotid plaques at a higher risk of atero-thrombotic brain events.;Secondary Objective: n.a.;Primary end point(s): evaluation of association between increase of signal 11[C] PK11195 in plaque and presence/onset brain lesions detected by brain MRI;Timepoint(s) of evaluation of this end point: to 18 months Follow Up

Secondary

MeasureTime frame
Secondary end point(s): n.a.;Timepoint(s) of evaluation of this end point: n.a.

Countries

Italy

Contacts

Public ContactDip. cardio-toraco-vascolare

Fondazione San Raffaele del Monte Tabor

ammirati.enrico@hsr.it0226436219

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026